Bi(2)S(3)/Ti(3)C(2)-TPP nano-heterostructures induced by near-infrared for photodynamic therapy combined with photothermal therapy on hypoxic tumors

近红外诱导的Bi(2)S(3)/Ti(3)C(2)-TPP纳米异质结构用于光动力疗法联合光热疗法治疗乏氧肿瘤

阅读:2

Abstract

BACKGROUND: Photodynamic therapy (PDT) efficacy of bismuth sulfide (Bi(2)S(3)) semiconductor has been severely restricted by its electron-hole pairs (e(-)-h(+)) separation inefficiency and oxygen (O(2)) deficiency in tumors, which greatly hinders reactive oxygen species (ROS) generation and further clinical application of Bi(2)S(3) nanoparticles (NPs) in biomedicine. RESULTS: Herein, novel Bi(2)S(3)/titanium carbide (Ti(3)C(2)) two-dimensional nano-heterostructures (NHs) are designed to realize multimode PDT of synchronous O(2) self-supply and ROS generation combined with highly efficient photothermal tumor elimination for hypoxic tumor therapy. Bi(2)S(3)/Ti(3)C(2) NHs were synthesized via the in situ synthesis method starting from Ti(3)C(2) nanosheets (NSs), a classical type of MXene nanostructure. Compared to simple Bi(2)S(3) NPs, Bi(2)S(3)/Ti(3)C(2) NHs significantly extend the absorption to the near-infrared (NIR) region and enhance the photocatalytic activity owing to the improved photogenerated carrier separation, where the hole on the valence band (VB) of Bi(2)S(3) can react with water to supply O(2) for the electron on the Ti(3)C(2) NSs to generate ·O(2)(-) and ·OH through electron transfer. Furthermore, they also achieve (1)O(2) generation through energy transfer due to O(2) self-supply. After the modification of triphenylphosphium bromide (TPP) on Bi(2)S(3)/Ti(3)C(2) NHs, systematic in vitro and in vivo evaluations were conducted, revealing that the synergistic-therapeutic outcome of this nanoplatform enables complete eradication of the U251 tumors without recurrence by NIR laser irradiation, and it can be used for computed tomography (CT) imaging because of the strong X-ray attenuation ability. CONCLUSION: This work expands the phototherapeutic effect of Bi(2)S(3)-based nanoplatforms, providing a new strategy for hypoxic tumor theranostics.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。